Announcements Trials
Browse Landscape

Phase

Phase 2 43Phase 3 29Phase 1 18Phase NA 10Phase 1/2 6Phase EARLY_PHASE1 2Phase 4 1Phase 2/3 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 3Lymphoid 3Gastrointestinal 3Head & Neck 2Genitourinary 2Classical hematology 2Breast 2Tumor-Agnostic 1Sarcoma 1Plasma cell 1Other hematologic neoplasm 1Myeloid 1Gynecologic 1Dermatologic 1CNS 1

Conditions

Uterine Cervical Neoplasms 1Anemia 1

Interventions

Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 10human papillomavirus vaccine, L1 type 16, 18 7olaparib 4niraparib 4Human Papillomavirus Recombinant Vaccine nonavalent 4Vaccines 3Saline Solution 3Papillomavirus Vaccines 3Medroxyprogesterone Acetate 3Carboplatin 3Bevacizumab 3pegylated granulocyte colony-stimulating factor 2liposomal doxorubicin 2fluciclovine F-18 2apatinib 2Sevoflurane 2Propofol 2Paclitaxel 2Aspirin 2semaglutide 1pegfilgrastim 1pazopanib 1palbociclib 1lenvatinib 1halofantrine 1ganirelix 1gadofosveset trisodium 1fosaprepitant 1follicle stimulating hormone, human, with HCG C-terminal peptide 1ferrous gluconate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 4 × Radiotherapy × Gynecologic × Clear all
NCT00046969 2013-05-30

Epoetin Beta in Treating Anemia in Patients With Cervical Cancer

National Cancer Institute (NCI)

Phase 4 Completed
450 enrolled
Classical hematologyGynecologic

Anemia, Uterine Cervical Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡